Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.
Atlas Molecular Pharma has raised $3.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2022.
Atlas Molecular Pharma's investors include Inveready, Kereon Partners, CDTI, Ezten Venture Capital Fund.
Atlas Molecular Pharma is headquartered in Derio, Spain.
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.
Atlas Molecular Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atlas Molecular Pharma — Funding & Investors." VCBacked, February 1, 2022, https://www.vcbacked.co/company/atlas-molecular-pharma. Accessed August 14, 2026.
VCBacked. (2022). Atlas Molecular Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/atlas-molecular-pharma
{{cite web |title=Atlas Molecular Pharma — Funding & Investors |url=https://www.vcbacked.co/company/atlas-molecular-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated